EVA RAISOR: Open Payments
NPI 1528304300 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,745 in 86 payments from 15 companies in 2025. Trend: 2023 $1,539 · 2024 $1,469 · 2025 $1,745
Food & beverage: $1,745
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $493 |
| CSL Behring | 5 | $220 |
| AstraZeneca Pharmaceuticals LP | 11 | $200 |
| GENZYME CORPORATION | 19 | $180 |
| GlaxoSmithKline, LLC. | 9 | $142 |
| Novartis Pharmaceuticals Corporation | 6 | $124 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $110 |
| Genentech USA, Inc. | 2 | $48 |
| Octapharma USA, Inc. | 2 | $42 |
| Amgen Inc. | 2 | $40 |
Products named: DUPIXENT, Andembry, NUCALA, NEFFY, Xolair, Haegarda, AIRSUPRA, FASENRA.
Industry payments across NY — which companies pay providers there.
